|
|
Last Modified: 4/1/2000  First Published: 6/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Supportive care
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
RNSMC-AM9702 ALZA-RNSMC-AM9702, NCI-V98-1390, NCT00003252
|
|
|
|
|
|
|
|
Last Modified: 11/1/2001  First Published: 11/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
18 to physiologic 74
|
|
|
|
NCI
|
|
|
|
UPCC-00-A-0465 NCI-T87-0232
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase I
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
no age specified
|
|
|
|
|
|
|
|
AECM-8908198 NCI-V92-0084
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
USB-WR-38 NCI-V96-1083
|
|
|
|
|
|
|
|
Last Modified: 5/23/2007  First Published: 12/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
UCMC-971163 ALZA-UCMC-971163, NCI-V97-1330
|
|
|
|
|
|
|
|
Last Modified: 6/3/2008  First Published: 7/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RTOG-9801 NCT00003313, RTOG-98-01
|
|
|
|
|
|
|
|
Last Modified: 8/1/1998  First Published: 8/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
21 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
BOSTON-VAMC-523 ALZA-97-047-ii, NCI-V98-1422
|
|
|
|
|
|
|
|
Last Modified: 6/1/2007  First Published: 12/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NU-97CC4 NCI-G99-1633, NCT00004166
|
|
|
|
|
|
|
|
Last Modified: 11/27/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
no age specified
|
|
|
|
NCI
|
|
|
|
EST-1686
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CLB-9160 CALGB-9160
|
|
|
|